Both in Pharmaceuticals
Decoy Therapeutics vs Valion Bio
Over the past year DCOY returned −59.9% and VBIO returned −75.7%; their daily moves had a correlation of -0.04.
DCOY −59.9% VBIO −75.7%Growth of $1, one year, split-adjusted
| Metric | DCOY | VBIO |
|---|---|---|
| Price | $1.07 | $0.5500 |
| Market cap | $701.0K | $1.2M |
| Today | −13.01% | −10.83% |
| 1 month | −42.3% | −78.1% |
| 6 months | −81.9% | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1042.8% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.3M | -$5.3M |
| Dividend yield | — | — |
| Volatility (60d) | 121.8% | — |
| Short % of float | 16.8% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).